Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance

Journal of Clinical Microbiology

Volumn 48, Issue 9, 2010, Pages 3127-3131

  Jang, Hyunjung ^a   Kim, Jihyun ^a   Choi, Jae Jin ^a   Son, Yeojin ^a   Park, Heekyung ^a  

^a Panagene Inc   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ENTECAVIR; LAMIVUDINE; PEPTIDE NUCLEIC ACID; VIRUS DNA;

ANTIVIRAL RESISTANCE; ARTICLE; GENETIC POLYMORPHISM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MICROARRAY ANALYSIS; MOLECULAR PROBE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS CONCENTRATION; VIRUS DETECTION;

ADENINE; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; GUANINE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE NUCLEIC ACIDS; PHOSPHONIC ACIDS; POINT MUTATION; SENSITIVITY AND SPECIFICITY;

HEPATITIS B VIRUS;

EID: 77956855917     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02058-09     Document Type: Article

References (28)

1. Allen, M. I., J. Gauthier, M. DesLauriers, E. J. Bourne, K. M. Carrick, F. Baldanti, L. L. Ross, M. W. Lutz, and L. D. Condreay. 1999. Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine. J. Clin. Microbiol. 37:3338-3347.
2. Beuvink, I., F. A. Kolb, W. Budach, A. Garnier, J. Lange, F. Natt, U. Dengler, J. Hall, W. Filipowicz, and J. Weiler. 2007. A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs. Nucleic Acids Res. 7:e52.
3. Brandt, O., and J. D. Hoheisel. 2004. Peptide nucleic acids on microarrays and other biosensors. Trends Biotechnol. 22:617-622.
4. Brandt, O., J. Feldner, A. Stephan, M. Schröder, M. Schnölzer, H. F. Arlinghaus, J. D. Hoheisel, and A. Jacob. 2003. PNA microarrays for hybridisation of unlabelled DNA samples. Nucleic Acids Res. 31:e119.
5. Chen, L. Y., J. Huang, X. P. Zhang, P. Qiao, W. Zhang, N. M. Yang, H. J. Liu, Y. Y. Geng, J. M. Qiu, and S. Q. Wang. 2005. Clinical evaluation of oligonucleotide microarrays for the detection of HBV mutants associated with lamivudine resistance. Pharmacogenomics 6:721-730.
6. Choi, J. J., C. Kim, and H. Park. 2009. Peptide nucleic acid-based array for detecting and genotyping human papillomaviruses. J. Clin. Microbiol. 47:1785-1790.
7. Choi, J. J., M. J. Jang, J. H. Kim, and H. K. Park. 2010. Highly sensitive PNA array platform technology for single nucleotide mismatch discrimination. J. Microbiol. Biotechnol. 20:287-293.
8. Degertekin, B., M. Hussain, J. Tan, K. Oberhelman, and A. S. Lok. 2009. Sensitivity and accuracy of an updated line probe assay (HBV DR v. 3) in detecting mutations associated with hepatitis B antiviral resistance. J. Hepatol. 50:42-48.
9. García-Quintanilla, A., L. Garcia, G. Tudó, M. Navarro, J. González, and M. T. Jiménez de Anta. 2000. Single-tube balanced heminested PCR for detecting Mycobacterium tuberculosis in smear-negative samples. J. Clin. Microbiol. 38:1166-1169.
10. Germini, A., A. Mezzelani, F. Lesignoli, R. Corradini, R. Marchelli, R. Bordoni, C. Consolandi, and G. De Bellis. 2004. Detection of genetically modified soybean using peptide nucleic acids (PNAs) and microarray technology. J. Agric. Food Chem. 52:4535-4540.
11. Hong, S. P., N. K. Kim, S. G. Hwang, H. J. Chung, S. Kim, J. H. Han, H. T. Kim, K. S. Rim, M. S. Kang, W. Yoo, and S. O. Kim. 2004. Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments. J. Hepatol. 40:837-844.
12. Hussain, M., S. Fung, E. Libbrecht, E. Sablon, C. Cursaro, P. Andreone, and A. S. Lok. 2006. Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir. J. Clin. Microbiol. 44:1094-1097.
13. Jang, H. J., M. Cho, J. Heo, H. Kim, H. Jun, W. Shin, B. Cho, H. Park, and C. Kim. 2004. Oligonucleotide chip for detection of lamivudine-resistant hepatitis B virus. J. Clin. Microbiol. 42:4181-4188.
14. Jensen, K. K., H. Orum, P. E. Nielsen, and B. Nordén. 1997. Kinetics for hybridization of peptide nucleic acids (PNA) with DNA and RNA studied with the BIAcore technique. Biochemistry 36:5072-5077.
15. Karkare, S., and D. Bhatnagar. 2006. Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino. Appl. Microbiol. Biotechnol. 71:575-586.
16. Keeffe, E. B., D. T. Dieterich, J. M. Pawlotsky, and Y. Benhamou. 2008. Chronic hepatitis B: preventing, detecting, and managing viral resistance. Clin. Gastroenterol. Hepatol. 6:268-274.
17. Kim, J. K., H. J. Lee, Y. J. Lee, J. Y. Chun, I. K. Lee, Y. S. Lim, D. J. Suh, S. Y. Ko, M. H. Kim, and H. B. Oh. 2008. Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers. J. Virol. Methods 149:76-84.
18. Lee, H., J. H. Jeon, J. C. Lim, H. Choi, Y. Yoon, and S. K. Kim. 2007. Peptide nucleic acid synthesis by novel amide formation. Org. Lett. 9:3291-3293.
19. Libbrecht, E., J. Doutreloigne, H. Van De Velde, M. F. Yuen, C. L. Lai, F. Shapiro, and E. Sablon. 2007. Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay. J. Clin. Microbiol. 45:3935-3941.
20. Lok, A. S., F. Zoulim, S. Locarnini, A. Bartholomeusz, M. G. Ghany, J. M. Pawlotsky, Y. F. Liaw, M. Mizokami, C. Kuiken, et al. 2007. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46:254-265.
21. Lok, A. S., F. Zoulim, S. Locarnini, A. Mangia, G. Niro, H. Decraemer, G. Maertens, F. Hulstaert, K. De Vreese, and E. Sablon. 2002. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay. J. Clin. Microbiol. 40:3729-3734.
22. Mikhailovich, V., D. Gryadunov, A. Kolchinsky, A. A. Makarov, and A. Zasedatelev. 2008. DNA microarrays in the clinic: infectious diseases. Bioessays 30:673-682.
23. Osiowy, C., J. P. Villeneuve, E. J. Heathcote, E. Giles, and J. Borlang. 2006. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). J. Clin. Microbiol. 44:1994-1997. (Pubitemid 43902144)
24. Shakeel, S., S. Karim, and A. Ali. 2006. Peptide nucleic acid (PNA)-a review. J. Chem. Technol. Biotechnol. 81:892-899.
25. Shaw, T., A. Bartholomeusz, and S. Locarnini. 2006. HBV drug resistance: mechanisms, detection and interpretation. J. Hepatol. 44:593-606. (Pubitemid 43227885)
26. Valsamakis, A. 2007. Molecular testing in the diagnosis and management of chronic hepatitis B. Clin. Microbiol. Rev. 20:426-439.
27. Wolff, C., D. Hörnschemeyer, D. Wolff, and K. Kleesiek. 1995. Single-tube nested PCR with room-temperature-stable reagents. PCR Methods Appl. 4:376-379.
28. Yoo, S. M., J. H. Choi, S. Y. Lee, and N. C. Yoo. 2009. Application of DNA microarray in disease diagnostics. J. Microbiol. Biotechnol. 19:635-646.